CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Oct 1, 2026
2. SEC Identification Number
168063
3. BIR Tax Identification No.
000-065-142-000
4. Exact name of issuer as specified in its charter
PRYCE CORPORATION
5. Province, country or other jurisdiction of incorporation
Philippines
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
17F Pryce Center 1179 Don Chino Roces Ave. corner Bagtikan Street, Makati CityPostal Code1203
8. Issuer's telephone number, including area code
(+632) 8899 4401
9. Former name or former address, if changed since last report
-
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common
1,880,546,169
Treasury
143,953,831
11. Indicate the item numbers reported herein
Item 9
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Pryce CorporationPPC
PSE Disclosure Form 4-31 - Press Release References: SRC Rule 17 (SEC Form 17-C) Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
PRYCE CORPORATION REMOVES PHARMACEUTICAL BUSINESS
Background/Description of the Disclosure
Please see attached disclosure entitled, "PRYCE CORPORATION REMOVES PHARMACEUTICAL BUSINESS".
Other Relevant Information
This amendment is being made to correct the contents of the attachment herein, particularly with regard to the inclusion of the actual press release.
The SEC 17-C (Current Report) and the necessary Secretary's Certificates will be submitted to the Commission and PSE together with the corresponding Press Release.